A comprehensive gene–environment interaction analysis in Ovarian Cancer using genome-wide significant common variants

Sehee Kim; Miao Wang; Jonathan P. Tyrer; Allan Jensen; Ashley Wiensch; Gang Liu; Alice W. Lee; Roberta B. Ness; Maxwell Salvatore; Shelley S. Tworoger; Alice S. Whittemore; Hoda Anton-Culver; Weiva Sieh; Sara H. Olson; Andrew Berchuck; Ellen L Goode; Marc T. Goodman; Jennifer Anne Doherty; Georgia Chenevix-Trench; Mary Anne Rossing; Penelope M. Webb; Graham G. Giles; Kathryn L. Terry; Argyrios Ziogas; Renée T. Fortner; Usha Menon; Simon A. Gayther; Anna H. Wu; Honglin Song; Angela Brooks-Wilson; Elisa V. Bandera; Linda S. Cook; Daniel W. Cramer; Roger L. Milne; Stacey J Winham; Susanne K. Kjaer; Francesmary Modugno; Pamela J. Thompson; Jenny Chang-Claude; Holly R. Harris; Joellen M. Schildkraut; Nhu D. Le; Nico Wentzensen; Britton Trabert; Estrid Høgdall; David Huntsman; Malcolm C. Pike; Paul D.P. Pharoah; Celeste Leigh Pearce; Bhramar Mukherjee

doi:10.1002/ijc.32029

A comprehensive gene–environment interaction analysis in Ovarian Cancer using genome-wide significant common variants

Sehee Kim, Miao Wang, Jonathan P. Tyrer, Allan Jensen, Ashley Wiensch, Gang Liu, Alice W. Lee, Roberta B. Ness, Maxwell Salvatore, Shelley S. Tworoger, Alice S. Whittemore, Hoda Anton-Culver, Weiva Sieh, Sara H. Olson, Andrew Berchuck, Ellen L Goode, Marc T. Goodman, Jennifer Anne Doherty, Georgia Chenevix-Trench, Mary Anne RossingPenelope M. Webb, Graham G. Giles, Kathryn L. Terry, Argyrios Ziogas, Renée T. Fortner, Usha Menon, Simon A. Gayther, Anna H. Wu, Honglin Song, Angela Brooks-Wilson, Elisa V. Bandera, Linda S. Cook, Daniel W. Cramer, Roger L. Milne, Stacey J Winham, Susanne K. Kjaer, Francesmary Modugno, Pamela J. Thompson, Jenny Chang-Claude, Holly R. Harris, Joellen M. Schildkraut, Nhu D. Le, Nico Wentzensen, Britton Trabert, Estrid Høgdall, David Huntsman, Malcolm C. Pike, Paul D.P. Pharoah, Celeste Leigh Pearce, Bhramar Mukherjee

Health Sciences Research

Research output: Contribution to journal › Article

1 Scopus citations

Abstract

As a follow-up to genome-wide association analysis of common variants associated with ovarian carcinoma (cancer), our study considers seven well-known ovarian cancer risk factors and their interactions with 28 genome-wide significant common genetic variants. The interaction analyses were based on data from 9971 ovarian cancer cases and 15,566 controls from 17 case–control studies. Likelihood ratio and Wald tests for multiplicative interaction and for relative excess risk due to additive interaction were used. The top multiplicative interaction was noted between oral contraceptive pill (OCP) use (ever vs. never) and rs13255292 (p value = 3.48 × 10⁻⁴). Among women with the TT genotype for this variant, the odds ratio for OCP use was 0.53 (95% CI = 0.46–0.60) compared to 0.71 (95%CI = 0.66–0.77) for women with the CC genotype. When stratified by duration of OCP use, women with 1–5 years of OCP use exhibited differential protective benefit across genotypes. However, no interaction on either the multiplicative or additive scale was found to be statistically significant after multiple testing correction. The results suggest that OCP use may offer increased benefit for women who are carriers of the T allele in rs13255292. On the other hand, for women carrying the C allele in this variant, longer (5+ years) use of OCP may reduce the impact of carrying the risk allele of this SNP. Replication of this finding is needed. The study presents a comprehensive analytic framework for conducting gene–environment analysis in ovarian cancer.

Original language	English (US)
Journal	International Journal of Cancer
DOIs	https://doi.org/10.1002/ijc.32029
State	Accepted/In press - Jan 1 2019

Fingerprint

Keywords

additive interaction
G × E
genetics
ovarian cancer

ASJC Scopus subject areas

Oncology
Cancer Research

Cite this

Kim, S., Wang, M., Tyrer, J. P., Jensen, A., Wiensch, A., Liu, G., Lee, A. W., Ness, R. B., Salvatore, M., Tworoger, S. S., Whittemore, A. S., Anton-Culver, H., Sieh, W., Olson, S. H., Berchuck, A., Goode, E. L., Goodman, M. T., Doherty, J. A., Chenevix-Trench, G., ... Mukherjee, B. (Accepted/In press). A comprehensive gene–environment interaction analysis in Ovarian Cancer using genome-wide significant common variants. International Journal of Cancer. https://doi.org/10.1002/ijc.32029

A comprehensive gene–environment interaction analysis in Ovarian Cancer using genome-wide significant common variants. / Kim, Sehee; Wang, Miao; Tyrer, Jonathan P.; Jensen, Allan; Wiensch, Ashley; Liu, Gang; Lee, Alice W.; Ness, Roberta B.; Salvatore, Maxwell; Tworoger, Shelley S.; Whittemore, Alice S.; Anton-Culver, Hoda; Sieh, Weiva; Olson, Sara H.; Berchuck, Andrew; Goode, Ellen L; Goodman, Marc T.; Doherty, Jennifer Anne; Chenevix-Trench, Georgia; Rossing, Mary Anne; Webb, Penelope M.; Giles, Graham G.; Terry, Kathryn L.; Ziogas, Argyrios; Fortner, Renée T.; Menon, Usha; Gayther, Simon A.; Wu, Anna H.; Song, Honglin; Brooks-Wilson, Angela; Bandera, Elisa V.; Cook, Linda S.; Cramer, Daniel W.; Milne, Roger L.; Winham, Stacey J; Kjaer, Susanne K.; Modugno, Francesmary; Thompson, Pamela J.; Chang-Claude, Jenny; Harris, Holly R.; Schildkraut, Joellen M.; Le, Nhu D.; Wentzensen, Nico; Trabert, Britton; Høgdall, Estrid; Huntsman, David; Pike, Malcolm C.; Pharoah, Paul D.P.; Pearce, Celeste Leigh; Mukherjee, Bhramar.

In: International Journal of Cancer, 01.01.2019.

Research output: Contribution to journal › Article

Kim, S, Wang, M, Tyrer, JP, Jensen, A, Wiensch, A, Liu, G, Lee, AW, Ness, RB, Salvatore, M, Tworoger, SS, Whittemore, AS, Anton-Culver, H, Sieh, W, Olson, SH, Berchuck, A, Goode, EL, Goodman, MT, Doherty, JA, Chenevix-Trench, G, Rossing, MA, Webb, PM, Giles, GG, Terry, KL, Ziogas, A, Fortner, RT, Menon, U, Gayther, SA, Wu, AH, Song, H, Brooks-Wilson, A, Bandera, EV, Cook, LS, Cramer, DW, Milne, RL, Winham, SJ, Kjaer, SK, Modugno, F, Thompson, PJ, Chang-Claude, J, Harris, HR, Schildkraut, JM, Le, ND, Wentzensen, N, Trabert, B, Høgdall, E, Huntsman, D, Pike, MC, Pharoah, PDP, Pearce, CL & Mukherjee, B 2019, 'A comprehensive gene–environment interaction analysis in Ovarian Cancer using genome-wide significant common variants', International Journal of Cancer. https://doi.org/10.1002/ijc.32029

Kim, Sehee ; Wang, Miao ; Tyrer, Jonathan P. ; Jensen, Allan ; Wiensch, Ashley ; Liu, Gang ; Lee, Alice W. ; Ness, Roberta B. ; Salvatore, Maxwell ; Tworoger, Shelley S. ; Whittemore, Alice S. ; Anton-Culver, Hoda ; Sieh, Weiva ; Olson, Sara H. ; Berchuck, Andrew ; Goode, Ellen L ; Goodman, Marc T. ; Doherty, Jennifer Anne ; Chenevix-Trench, Georgia ; Rossing, Mary Anne ; Webb, Penelope M. ; Giles, Graham G. ; Terry, Kathryn L. ; Ziogas, Argyrios ; Fortner, Renée T. ; Menon, Usha ; Gayther, Simon A. ; Wu, Anna H. ; Song, Honglin ; Brooks-Wilson, Angela ; Bandera, Elisa V. ; Cook, Linda S. ; Cramer, Daniel W. ; Milne, Roger L. ; Winham, Stacey J ; Kjaer, Susanne K. ; Modugno, Francesmary ; Thompson, Pamela J. ; Chang-Claude, Jenny ; Harris, Holly R. ; Schildkraut, Joellen M. ; Le, Nhu D. ; Wentzensen, Nico ; Trabert, Britton ; Høgdall, Estrid ; Huntsman, David ; Pike, Malcolm C. ; Pharoah, Paul D.P. ; Pearce, Celeste Leigh ; Mukherjee, Bhramar. / A comprehensive gene–environment interaction analysis in Ovarian Cancer using genome-wide significant common variants. In: International Journal of Cancer. 2019.

@article{df53f45793eb4aa880f484305d02e030,

title = "A comprehensive gene–environment interaction analysis in Ovarian Cancer using genome-wide significant common variants",

abstract = "As a follow-up to genome-wide association analysis of common variants associated with ovarian carcinoma (cancer), our study considers seven well-known ovarian cancer risk factors and their interactions with 28 genome-wide significant common genetic variants. The interaction analyses were based on data from 9971 ovarian cancer cases and 15,566 controls from 17 case–control studies. Likelihood ratio and Wald tests for multiplicative interaction and for relative excess risk due to additive interaction were used. The top multiplicative interaction was noted between oral contraceptive pill (OCP) use (ever vs. never) and rs13255292 (p value = 3.48 × 10−4). Among women with the TT genotype for this variant, the odds ratio for OCP use was 0.53 (95% CI = 0.46–0.60) compared to 0.71 (95%CI = 0.66–0.77) for women with the CC genotype. When stratified by duration of OCP use, women with 1–5 years of OCP use exhibited differential protective benefit across genotypes. However, no interaction on either the multiplicative or additive scale was found to be statistically significant after multiple testing correction. The results suggest that OCP use may offer increased benefit for women who are carriers of the T allele in rs13255292. On the other hand, for women carrying the C allele in this variant, longer (5+ years) use of OCP may reduce the impact of carrying the risk allele of this SNP. Replication of this finding is needed. The study presents a comprehensive analytic framework for conducting gene–environment analysis in ovarian cancer.",

keywords = "additive interaction, G × E, genetics, ovarian cancer",

author = "Sehee Kim and Miao Wang and Tyrer, {Jonathan P.} and Allan Jensen and Ashley Wiensch and Gang Liu and Lee, {Alice W.} and Ness, {Roberta B.} and Maxwell Salvatore and Tworoger, {Shelley S.} and Whittemore, {Alice S.} and Hoda Anton-Culver and Weiva Sieh and Olson, {Sara H.} and Andrew Berchuck and Goode, {Ellen L} and Goodman, {Marc T.} and Doherty, {Jennifer Anne} and Georgia Chenevix-Trench and Rossing, {Mary Anne} and Webb, {Penelope M.} and Giles, {Graham G.} and Terry, {Kathryn L.} and Argyrios Ziogas and Fortner, {Ren{\'e}e T.} and Usha Menon and Gayther, {Simon A.} and Wu, {Anna H.} and Honglin Song and Angela Brooks-Wilson and Bandera, {Elisa V.} and Cook, {Linda S.} and Cramer, {Daniel W.} and Milne, {Roger L.} and Winham, {Stacey J} and Kjaer, {Susanne K.} and Francesmary Modugno and Thompson, {Pamela J.} and Jenny Chang-Claude and Harris, {Holly R.} and Schildkraut, {Joellen M.} and Le, {Nhu D.} and Nico Wentzensen and Britton Trabert and Estrid H{\o}gdall and David Huntsman and Pike, {Malcolm C.} and Pharoah, {Paul D.P.} and Pearce, {Celeste Leigh} and Bhramar Mukherjee",

year = "2019",

month = jan

day = "1",

doi = "10.1002/ijc.32029",

language = "English (US)",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - A comprehensive gene–environment interaction analysis in Ovarian Cancer using genome-wide significant common variants

AU - Kim, Sehee

AU - Wang, Miao

AU - Tyrer, Jonathan P.

AU - Jensen, Allan

AU - Wiensch, Ashley

AU - Liu, Gang

AU - Lee, Alice W.

AU - Ness, Roberta B.

AU - Salvatore, Maxwell

AU - Tworoger, Shelley S.

AU - Whittemore, Alice S.

AU - Anton-Culver, Hoda

AU - Sieh, Weiva

AU - Olson, Sara H.

AU - Berchuck, Andrew

AU - Goode, Ellen L

AU - Goodman, Marc T.

AU - Doherty, Jennifer Anne

AU - Chenevix-Trench, Georgia

AU - Rossing, Mary Anne

AU - Webb, Penelope M.

AU - Giles, Graham G.

AU - Terry, Kathryn L.

AU - Ziogas, Argyrios

AU - Fortner, Renée T.

AU - Menon, Usha

AU - Gayther, Simon A.

AU - Wu, Anna H.

AU - Song, Honglin

AU - Brooks-Wilson, Angela

AU - Bandera, Elisa V.

AU - Cook, Linda S.

AU - Cramer, Daniel W.

AU - Milne, Roger L.

AU - Winham, Stacey J

AU - Kjaer, Susanne K.

AU - Modugno, Francesmary

AU - Thompson, Pamela J.

AU - Chang-Claude, Jenny

AU - Harris, Holly R.

AU - Schildkraut, Joellen M.

AU - Le, Nhu D.

AU - Wentzensen, Nico

AU - Trabert, Britton

AU - Høgdall, Estrid

AU - Huntsman, David

AU - Pike, Malcolm C.

AU - Pharoah, Paul D.P.

AU - Pearce, Celeste Leigh

AU - Mukherjee, Bhramar

PY - 2019/1/1

Y1 - 2019/1/1

N2 - As a follow-up to genome-wide association analysis of common variants associated with ovarian carcinoma (cancer), our study considers seven well-known ovarian cancer risk factors and their interactions with 28 genome-wide significant common genetic variants. The interaction analyses were based on data from 9971 ovarian cancer cases and 15,566 controls from 17 case–control studies. Likelihood ratio and Wald tests for multiplicative interaction and for relative excess risk due to additive interaction were used. The top multiplicative interaction was noted between oral contraceptive pill (OCP) use (ever vs. never) and rs13255292 (p value = 3.48 × 10−4). Among women with the TT genotype for this variant, the odds ratio for OCP use was 0.53 (95% CI = 0.46–0.60) compared to 0.71 (95%CI = 0.66–0.77) for women with the CC genotype. When stratified by duration of OCP use, women with 1–5 years of OCP use exhibited differential protective benefit across genotypes. However, no interaction on either the multiplicative or additive scale was found to be statistically significant after multiple testing correction. The results suggest that OCP use may offer increased benefit for women who are carriers of the T allele in rs13255292. On the other hand, for women carrying the C allele in this variant, longer (5+ years) use of OCP may reduce the impact of carrying the risk allele of this SNP. Replication of this finding is needed. The study presents a comprehensive analytic framework for conducting gene–environment analysis in ovarian cancer.

AB - As a follow-up to genome-wide association analysis of common variants associated with ovarian carcinoma (cancer), our study considers seven well-known ovarian cancer risk factors and their interactions with 28 genome-wide significant common genetic variants. The interaction analyses were based on data from 9971 ovarian cancer cases and 15,566 controls from 17 case–control studies. Likelihood ratio and Wald tests for multiplicative interaction and for relative excess risk due to additive interaction were used. The top multiplicative interaction was noted between oral contraceptive pill (OCP) use (ever vs. never) and rs13255292 (p value = 3.48 × 10−4). Among women with the TT genotype for this variant, the odds ratio for OCP use was 0.53 (95% CI = 0.46–0.60) compared to 0.71 (95%CI = 0.66–0.77) for women with the CC genotype. When stratified by duration of OCP use, women with 1–5 years of OCP use exhibited differential protective benefit across genotypes. However, no interaction on either the multiplicative or additive scale was found to be statistically significant after multiple testing correction. The results suggest that OCP use may offer increased benefit for women who are carriers of the T allele in rs13255292. On the other hand, for women carrying the C allele in this variant, longer (5+ years) use of OCP may reduce the impact of carrying the risk allele of this SNP. Replication of this finding is needed. The study presents a comprehensive analytic framework for conducting gene–environment analysis in ovarian cancer.

KW - additive interaction

KW - G × E

KW - genetics

KW - ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=85060352233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060352233&partnerID=8YFLogxK

U2 - 10.1002/ijc.32029

DO - 10.1002/ijc.32029

M3 - Article

C2 - 30499236

AN - SCOPUS:85060352233

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

ER -

Access to Document

10.1002/ijc.32029